Silexion Therapeutics Corp Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2023 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Silexion Therapeutics Corp quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2023 to Q2 2025.
  • Silexion Therapeutics Corp Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2025 was $472K, a 237% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2025 $472K +$332K +237% Jun 30, 2025 10-Q 2025-08-12
Q1 2025 $502K Mar 31, 2025 10-Q 2025-05-13
Q4 2024 $530K +$332K +168% Dec 31, 2024 8-K 2025-08-20
Q3 2024 $0 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $140K Jun 30, 2024 10-Q 2024-08-29
Q4 2023 $198K Dec 31, 2023 8-K 2025-08-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.